Researchers are now finding links between Down’s syndrome and drugs used in in-vitro fertilization (IVF) for older women.

A test that uses the latest DNA technology to analyze genetic components in a pregnant woman's blood could predict Down's syndrome in unborn babies, according to new research.

Researchers say that a blood test during pregnancy could one day replace more invasive tests for Down's syndrome.

Research undertaken in recent years on Down’s syndrome has focused on the DYRK1A gene.

A newly identified molecular pathway that directs stem cells to produce glial cells yields insights into the neurobiology of Down's syndrome and a number of central nervous system disorders characterized by too many glial cells, according to a recent study by researchers at the Salk Institute for Biological Studies.